Affiliation:
1. Jiangsu Key Laboratory for High Technology Research of TCM Formulae, Nanjing 210023, China
2. Jiangsu Collaborative Innovation Center of Chinese Medicinal Resource Industrialization, National and Local Collaborative Engineering Center of Chinese Medicinal Resources Industrialization, Formulae Innovative Medicine, Nanjing University of Chinese Medicine, Nanjing 210023, China
Abstract
According to the sixth edition of China’s “New Coronavirus Diagnosis and Treatment Plan (NCDTP),” ReDuNing injection (RDN) was firstly introduced to treat severe and critical COVID-19, whereas its combination with broad-spectrum antibiotics was suggested to take with extreme caution and full reasons. Therefore, we aim to describe the pharmacokinetics of seven active phytochemicals and semiquantification of nine relevant metabolites in ReDuNing injection (RDN) after combining with cefuroxime sodium (CNa) for injection in rat plasma. Male Sprague–Dawley rats were randomly assigned to six groups, and they were intravenously administered, respectively, with different prescriptions of RDN (2 mL/kg) and CNa (225 mg/kg). At different time points (0.03, 0.08, 0.17, 0.24, 0.33, 0.50, 0.67, 1, and 6 h) after administration, the drug concentrations of iridoids glycosides, organic acids, and metabolites in rat plasma were determined using ultrahigh-pressure liquid chromatography coupled with linear ion rap-orbitrap tandem mass spectrometry (UHPLC–LTQ–Orbitrap–MS), and main pharmacokinetic parameters were estimated by noncompartment model. The results showed that there were differences in pharmacokinetic parameters, AUC(0-t), T1/2, Cmax, CL of iridoids glycosides, and organic acids, after the intravenous administration of the different combinations of RDN and CNa. Moreover, different combinations of the injections also resulted in different curves of relative changes of each metabolite. The obtained results suggested that RDN and CNa existed pharmacokinetic drug–herb interactions in rats. The findings not only lay the foundation for evaluating the safety of RDN injection combined with CNa but also make contributions to clinically applying RDN injection combined with CNa, which works potentially against severe forms of COVID-19.
Funder
Jiangsu Collaborative Innovation Center of Chinese Medicinal Resources Industrialization
Subject
Computer Science Applications,Instrumentation,General Chemical Engineering,Analytical Chemistry
Reference60 articles.
1. Draft landscape and tracker of COVID-19 candidate vaccines;World Health Organization,2021
2. Neutralization of variant under investigation B.1.617 with sera of BBV152 vaccinees;P. D. Yadav;Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America,2021
3. Delta coronavirus variant: scientists brace for impact
4. Reduced sensitivity of SARS-CoV-2 variant Delta to antibody neutralization
5. Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates